Caxton Associates LP Danaher Corp Transaction History

Caxton Associates LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$224.99 - $256.14 $541,325 - $616,272	-2,406 Reduced 35.38%	4,394 $1.05 Million
Q1 2023 May 15, 2023	BUY	$239.75 - $277.0 $1.63 Million - $1.88 Million	6,800 New	6,800 $1.71 Million
Q4 2020 Feb 16, 2021	SELL	$212.5 - $245.46 $350,200 - $404,518	-1,648 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$177.16 - $215.33 $291,959 - $354,863	1,648 New	1,648 $355,000
Q4 2018 Feb 14, 2019	SELL	$94.85 - $109.54 $327,991 - $378,789	-3,458 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$98.13 - $108.9 $776,306 - $861,507	-7,911 Reduced 69.58%	3,458 $376,000
Q2 2018 Aug 14, 2018	BUY	$96.1 - $103.24 $1.09 Million - $1.17 Million	11,369 New	11,369 $1.12 Million
Q3 2017 Nov 14, 2017	SELL	$79.29 - $88.45 $562,959 - $627,995	-7,100 Closed	0 $0
Q2 2017 Aug 29, 2017	BUY	N/A	7,100	7,100 $599,000

2,488

545M

7.08M

4.48M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $151B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.